News about Global Pharma

BioMap Collaborates with Sanofi to Co-Develop AI Modules for Biotherapeutic Drug Discovery

BioMap is eligible to receive payments of more than $1 billion based on achievement of preclinical development, clinical development, regulatory, and commercial milestones.

Global Pharma | 11/10/2023 | By Manvi |  1012

Strides Gets USFDA Approval for Icosapent Ethyl Capsules

The product complements Strides' range of approved soft gelatin capsules.

Global Pharma | 09/10/2023 | By Manvi |  615

Marksans Pharma Announces US FDA Approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg

This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR DelayedRelease Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals LP.

Global Pharma | 09/10/2023 | By Manvi |  570

Sun Pharma to Acquire 38% Stake in EzeRx Health Tech for Rs 29 Crore

Sun Pharma will acquire a 37.76% equity shareholding in EzeRx at a cost of Rs 28.69 crore, according to a stock exchange filing.

Global Pharma | 09/10/2023 | By Manvi |  854

REFCOLD India 2023 Sets to Showcase India's Prowess in Refrigeration and Cold Chain Industry Map

The collaboration encompasses the presentation of cutting-edge technological solutions, forging new partnerships and unlocking business opportunities.

Global Pharma | 09/10/2023 | By Manvi |  392

Granules India's Losartan and Hydrochlorothiazide Tablets Gets US FDA Approval

These approved tablets are deemed bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Hyzaar Tablets, marketed by Organon LLC.

Global Pharma | 03/10/2023 | By Manvi |  968

Lupin Acquires Five Brands from Menarini

The brands are Piclin (Picosulphate Sodium), Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and Distaclor (Cefaclor).

Global Pharma | 26/09/2023 | By Manvi |  870

Croatian Pharma Producer JGL Completes 53 Million Euro Investment Project

The project, named INTEGRA, included construction of high-tech facilities on two locations near Rijeka, and took three years to complete, the company said.

Global Pharma | 26/09/2023 | By Manvi |  826

Aurobindo Pharma Signs MoU With GITAM

Aurobindo Pharma Limited entered a memorandum of understanding (MoU) with GITAM to train its employees from the Vizag cluster. As a part of the MoU, the institution will offer a custom designed management development programme (MDP) ‘Auro Astra’ to Aurobindo Pharma employees.

Global Pharma | 26/09/2023 | By Manvi |  1059

Quadria Capital-Backed Akums Kicks Off 2024 IPO Plans

Delhi-based Akums Drugs and Pharmaceuticals Ltd has picked four investment banks as advisors and kicked off the process to prepare for a listing in 2024.

Global Pharma | 26/09/2023 | By Manvi |  1431